Table 1.

Patient cohort with the range of the planned dose for the two studies.

Site	Number of Patients		Planned dose [Gy]
	Cohort 1	Cohort 2	Cohort 1	Cohort 2
Head & neck	18	14	30 – 70	46 – 70
Lung	16	8	20 – 66	46 – 66
Pelvic region	17	11	25 – 77	25 – 75
Prostate	21	5	65–77	77